Last 12 months
Inside the activity.
3 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 2 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2020 Filed Jan 6, 2020 16:04 UTC |
Hlavinka Sarah E.Director
|
GrantCommon Stock | 2,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-000207 · primarydocument.xml · nonDerivative · entry 1 Hlavinka Sarah E. · CIK 0001433554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,130 F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2020 granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 6,810 restricted stock units. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:04 UTC |
Madaus Martin DDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,900 | $0.00 Strike: $23.12 | $0.00 |
DisclosureSEC source: 0001562180-20-000208 · primarydocument.xml · derivative · entry 4 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,900 Underlying: Common Stock · 7,900 shares Expires 2030-01-02 F6 · shares: Represents non-qualified stock option to purchase 7,900 shares of common stock granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:04 UTC |
Madaus Martin DDirector
|
GrantCommon Stock | 782 | $23.12 | $18,079.84 |
DisclosureSEC source: 0001562180-20-000208 · primarydocument.xml · nonDerivative · entry 2 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,601 F3 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the fourth quarter of 2019. F4 · price: Closing price of the Company's common stock on the Nasdaq Global Market on January 2, 2020. F2 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:04 UTC |
Madaus Martin DDirector
|
GrantCommon Stock | 2,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-000208 · primarydocument.xml · nonDerivative · entry 1 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,819 F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2020 granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 16:04 UTC |
WALT DAVID RDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,900 | $0.00 Strike: $23.12 | $0.00 |
DisclosureSEC source: 0001562180-20-000210 · primarydocument.xml · derivative · entry 2 WALT DAVID R · CIK 0001205236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,900 Underlying: Common Stock · 7,900 shares Expires 2030-01-02 F3 · shares: Represents non-qualified stock option to purchase 7,900 shares of common stock granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 16:04 UTC |
WALT DAVID RDirector
|
GrantCommon Stock | 2,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-000210 · primarydocument.xml · nonDerivative · entry 1 WALT DAVID R · CIK 0001205236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,222,310 F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2020 granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 16:04 UTC |
DEKKERS MARIJN EDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,900 | $0.00 Strike: $23.12 | $0.00 |
DisclosureSEC source: 0001562180-20-000206 · primarydocument.xml · derivative · entry 3 DEKKERS MARIJN E · CIK 0001216068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,900 Underlying: Common Stock · 7,900 shares Expires 2030-01-02 F5 · shares: Represents non-qualified stock option to purchase 7,900 shares of common stock granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 16:04 UTC |
DEKKERS MARIJN EDirector
|
GrantCommon Stock | 2,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-000206 · primarydocument.xml · nonDerivative · entry 1 DEKKERS MARIJN E · CIK 0001216068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,810 F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2020 granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:04 UTC |
CRANDELL KEITHDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 7,900 | $0.00 Strike: $23.12 | $0.00 |
DisclosureSEC source: 0001562180-20-000205 · primarydocument.xml · derivative · entry 5 CRANDELL KEITH · CIK 0001219039 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,900 Underlying: Common Stock · 7,900 shares Expires 2030-01-02 F7 · shares: Represents non-qualified stock option to purchase 7,900 shares of common stock granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:04 UTC |
CRANDELL KEITHDirector · 10% owner
|
GrantCommon Stock | 508 | $23.12 | $11,744.96 |
DisclosureSEC source: 0001562180-20-000205 · primarydocument.xml · nonDerivative · entry 2 CRANDELL KEITH · CIK 0001219039 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,700 F3 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the fourth quarter of 2019. F4 · price: Closing price of the Company's common stock on the Nasdaq Global Market on January 2, 2020. F2 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:04 UTC |
CRANDELL KEITHDirector · 10% owner
|
GrantCommon Stock | 2,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-000205 · primarydocument.xml · nonDerivative · entry 1 CRANDELL KEITH · CIK 0001219039 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,192 F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2020 granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 16:04 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 3,321 | $23.18 | $76,965.50 |
DisclosureSEC source: 0001562180-20-000211 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,163,842 F1 · shares: The sales of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 7,123 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $22.96 to $23.42. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 181,873 restricted stock units. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:05 UTC |
Roskey Mark T.SVP, Commercial & Accelerator
|
SaleCommon Stock | 46 | $23.18 | $1,066.07 |
DisclosureSEC source: 0001562180-20-000213 · primarydocument.xml · nonDerivative · entry 1 Roskey Mark T. · CIK 0001724565 · SVP, Commercial & Accelerator 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,239 F1 · shares: The sales of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 148 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $22.96 to $23.42. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 11,393 restricted stock units. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:04 UTC |
Mattoon DawnSr. VP, Research Products
|
SaleCommon Stock | 115 | $23.18 | $2,665.17 |
DisclosureSEC source: 0001562180-20-000212 · primarydocument.xml · nonDerivative · entry 1 Mattoon Dawn · CIK 0001731785 · Sr. VP, Research Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,241 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 368 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $22.96 to $23.42. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 16,920 restricted stock units. Read SEC document |
| December 27, 2019 Filed Dec 30, 2019 21:23 UTC |
Madaus Martin DDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,600 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001562180-19-006288 · primarydocument.xml · derivative · entry 8 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,507 Underlying: Common Stock · 1,600 shares Expires 2021-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: All options are vested and exercisable. Read SEC document |
| December 27, 2019 Filed Dec 30, 2019 21:23 UTC |
Madaus Martin DDirector
|
SaleCommon Stock | 2,300 | $23.27 | $53,523.30 |
DisclosureSEC source: 0001562180-19-006288 · primarydocument.xml · nonDerivative · entry 6 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 206,566 F1 · kind: All sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person on September 9, 2019. F6 · price: This transaction was executed in multiple trades at prices ranging from $23.01 to $24.50. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · ownership.nature: Held by a trust for which the Reporting Person is a trust advisor who shares voting and investment control. Read SEC document |
| December 27, 2019 Filed Dec 30, 2019 21:23 UTC |
Madaus Martin DDirector
|
SaleCommon Stock | 1,600 | $23.63 | $37,806.40 |
DisclosureSEC source: 0001562180-19-006288 · primarydocument.xml · nonDerivative · entry 5 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,549 F1 · kind: All sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person on September 9, 2019. F5 · price: This transaction was executed in multiple trades at prices ranging from $23.60 to $23.75. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 27, 2019 Filed Dec 30, 2019 21:23 UTC |
Madaus Martin DDirector
|
Exercise / conversionCommon Stock | 1,600 | $1.93 | $3,088.00 |
DisclosureSEC source: 0001562180-19-006288 · primarydocument.xml · nonDerivative · entry 4 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,149 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 26, 2019 Filed Dec 30, 2019 21:23 UTC |
Madaus Martin DDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,600 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001562180-19-006288 · primarydocument.xml · derivative · entry 7 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,107 Underlying: Common Stock · 1,600 shares Expires 2021-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: All options are vested and exercisable. Read SEC document |
| December 26, 2019 Filed Dec 30, 2019 21:23 UTC |
Madaus Martin DDirector
|
SaleCommon Stock | 2,300 | $24.09 | $55,408.15 |
DisclosureSEC source: 0001562180-19-006288 · primarydocument.xml · nonDerivative · entry 3 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 208,866 F1 · kind: All sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person on September 9, 2019. F3 · price: This transaction was executed in multiple trades at prices ranging from $23.78 to $24.43. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · ownership.nature: Held by a trust for which the Reporting Person is a trust advisor who shares voting and investment control. Read SEC document |
| December 26, 2019 Filed Dec 30, 2019 21:23 UTC |
Madaus Martin DDirector
|
SaleCommon Stock | 1,600 | $24.25 | $38,795.20 |
DisclosureSEC source: 0001562180-19-006288 · primarydocument.xml · nonDerivative · entry 2 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,549 F1 · kind: All sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person on September 9, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $24.17 to $24.34. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 26, 2019 Filed Dec 30, 2019 21:23 UTC |
Madaus Martin DDirector
|
Exercise / conversionCommon Stock | 1,600 | $1.93 | $3,088.00 |
DisclosureSEC source: 0001562180-19-006288 · primarydocument.xml · nonDerivative · entry 1 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,149 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 18, 2019 Filed Dec 20, 2019 23:40 UTC |
Duffy David C.SVP R&D and CTO
|
Exercise / conversionStock Option (Right to buy) · Derivative | 6,600 | $0.00 Strike: $2.28 | $0.00 |
DisclosureSEC source: 0001562180-19-006222 · primarydocument.xml · derivative · entry 2 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,513 Underlying: Common Stock · 6,600 shares Expires 2022-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option is fully vested. Read SEC document |
| December 18, 2019 Filed Dec 20, 2019 23:40 UTC |
Duffy David C.SVP R&D and CTO
|
Exercise / conversionCommon Stock | 6,600 | $2.28 | $15,048.00 |
DisclosureSEC source: 0001562180-19-006222 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,360 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 8,949 restricted stock units. Read SEC document |
| December 16, 2019 Filed Dec 16, 2019 21:17 UTC |
Duffy David C.SVP R&D and CTO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,667 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001562180-19-006094 · primarydocument.xml · derivative · entry 3 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,941 Underlying: Common Stock · 1,667 shares Expires 2021-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option is fully vested. Read SEC document |
| December 16, 2019 Filed Dec 16, 2019 21:17 UTC |
Duffy David C.SVP R&D and CTO
|
SaleCommon Stock | 1,667 | $24.15 | $40,258.05 |
DisclosureSEC source: 0001562180-19-006094 · primarydocument.xml · nonDerivative · entry 2 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,760 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on May 16, 2019. F2 · balance_after: Includes 8,949 restricted stock units. Read SEC document |
| December 16, 2019 Filed Dec 16, 2019 21:17 UTC |
Duffy David C.SVP R&D and CTO
|
Exercise / conversionCommon Stock | 1,667 | $1.93 | $3,217.31 |
DisclosureSEC source: 0001562180-19-006094 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,427 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2019 Filed Dec 11, 2019 23:48 UTC |
Madaus Martin DDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,600 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001562180-19-006036 · primarydocument.xml · derivative · entry 8 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,707 Underlying: Common Stock · 1,600 shares Expires 2021-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: All options are vested and exercisable. Read SEC document |
| December 11, 2019 Filed Dec 11, 2019 23:48 UTC |
Madaus Martin DDirector
|
SaleCommon Stock | 2,300 | $25.36 | $58,321.33 |
DisclosureSEC source: 0001562180-19-006036 · primarydocument.xml · nonDerivative · entry 6 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 211,166 F1 · kind: All sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person on September 9, 2019. F4 · price: This transaction was executed in multiple trades at prices ranging from $24.96 to $25.77. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by a trust for which the Reporting Person is a trust advisor who shares voting and investment control. Read SEC document |
| December 11, 2019 Filed Dec 11, 2019 23:48 UTC |
Madaus Martin DDirector
|
SaleCommon Stock | 1,600 | $25.25 | $40,400.00 |
DisclosureSEC source: 0001562180-19-006036 · primarydocument.xml · nonDerivative · entry 5 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,549 F1 · kind: All sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person on September 9, 2019. Read SEC document |
| December 11, 2019 Filed Dec 11, 2019 23:48 UTC |
Madaus Martin DDirector
|
Exercise / conversionCommon Stock | 1,600 | $1.93 | $3,088.00 |
DisclosureSEC source: 0001562180-19-006036 · primarydocument.xml · nonDerivative · entry 4 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,149 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2019 Filed Dec 11, 2019 23:48 UTC |
Madaus Martin DDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,600 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001562180-19-006036 · primarydocument.xml · derivative · entry 7 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,307 Underlying: Common Stock · 1,600 shares Expires 2021-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: All options are vested and exercisable. Read SEC document |
| December 10, 2019 Filed Dec 11, 2019 23:48 UTC |
Madaus Martin DDirector
|
SaleCommon Stock | 2,300 | $25.13 | $57,793.02 |
DisclosureSEC source: 0001562180-19-006036 · primarydocument.xml · nonDerivative · entry 3 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 213,466 F1 · kind: All sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person on September 9, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $24.93 to $25.26. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by a trust for which the Reporting Person is a trust advisor who shares voting and investment control. Read SEC document |
| December 10, 2019 Filed Dec 11, 2019 23:48 UTC |
Madaus Martin DDirector
|
SaleCommon Stock | 1,600 | $24.81 | $39,696.00 |
DisclosureSEC source: 0001562180-19-006036 · primarydocument.xml · nonDerivative · entry 2 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,549 F1 · kind: All sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person on September 9, 2019. Read SEC document |
| December 10, 2019 Filed Dec 11, 2019 23:48 UTC |
Madaus Martin DDirector
|
Exercise / conversionCommon Stock | 1,600 | $1.93 | $3,088.00 |
DisclosureSEC source: 0001562180-19-006036 · primarydocument.xml · nonDerivative · entry 1 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,149 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2019 Filed Dec 3, 2019 20:29 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 3,357 | $25.06 | $84,136.16 |
DisclosureSEC source: 0001562180-19-005807 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,167,163 F1 · shares: The sales of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 7,123 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $24.99 to $25.13. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 188,996 restricted stock units. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 01:29 UTC |
Roskey Mark T.SVP, Commercial & Accelerator
|
SaleCommon Stock | 47 | $25.06 | $1,177.96 |
DisclosureSEC source: 0001562180-19-005809 · primarydocument.xml · nonDerivative · entry 1 Roskey Mark T. · CIK 0001724565 · SVP, Commercial & Accelerator 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,285 F1 · shares: The sales of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 148 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $24.99 to $25.13. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 11,541 restricted stock units. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 01:29 UTC |
Mattoon DawnSr. VP, Research Products
|
SaleCommon Stock | 115 | $25.06 | $2,882.23 |
DisclosureSEC source: 0001562180-19-005808 · primarydocument.xml · nonDerivative · entry 1 Mattoon Dawn · CIK 0001731785 · Sr. VP, Research Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,356 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 368 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $24.99 to $25.13. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 17,288 restricted stock units. Read SEC document |
| November 26, 2019 Filed Nov 26, 2019 22:33 UTC |
Madaus Martin DDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,600 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001562180-19-005746 · primarydocument.xml · derivative · entry 8 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,907 Underlying: Common Stock · 1,600 shares Expires 2021-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: All options are vested and exercisable. Read SEC document |
| November 26, 2019 Filed Nov 26, 2019 22:33 UTC |
Madaus Martin DDirector
|
SaleCommon Stock | 2,300 | $25.07 | $57,659.85 |
DisclosureSEC source: 0001562180-19-005746 · primarydocument.xml · nonDerivative · entry 6 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 215,766 F1 · kind: All sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person on September 9, 2019. F5 · price: This transaction was executed in multiple trades at prices ranging from $24.92 to $25.23. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · ownership.nature: Held by a trust for which the Reporting Person is a trust advisor who shares voting and investment control. Read SEC document |
| November 26, 2019 Filed Nov 26, 2019 22:33 UTC |
Madaus Martin DDirector
|
SaleCommon Stock | 1,600 | $25.40 | $40,640.00 |
DisclosureSEC source: 0001562180-19-005746 · primarydocument.xml · nonDerivative · entry 5 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,549 F1 · kind: All sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person on September 9, 2019. Read SEC document |
| November 26, 2019 Filed Nov 26, 2019 22:33 UTC |
Madaus Martin DDirector
|
Exercise / conversionCommon Stock | 1,600 | $1.93 | $3,088.00 |
DisclosureSEC source: 0001562180-19-005746 · primarydocument.xml · nonDerivative · entry 4 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,149 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 22:33 UTC |
Madaus Martin DDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,600 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001562180-19-005746 · primarydocument.xml · derivative · entry 7 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,507 Underlying: Common Stock · 1,600 shares Expires 2021-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: All options are vested and exercisable. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 22:33 UTC |
Madaus Martin DDirector
|
SaleCommon Stock | 2,300 | $25.40 | $58,425.06 |
DisclosureSEC source: 0001562180-19-005746 · primarydocument.xml · nonDerivative · entry 3 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 218,066 F1 · kind: All sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person on September 9, 2019. F3 · price: This transaction was executed in multiple trades at prices ranging from $24.96 to $25.805. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · ownership.nature: Held by a trust for which the Reporting Person is a trust advisor who shares voting and investment control. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 22:33 UTC |
Madaus Martin DDirector
|
SaleCommon Stock | 1,600 | $24.87 | $39,787.68 |
DisclosureSEC source: 0001562180-19-005746 · primarydocument.xml · nonDerivative · entry 2 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,549 F1 · kind: All sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person on September 9, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $24.77 to $24.935 The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 22:33 UTC |
Madaus Martin DDirector
|
Exercise / conversionCommon Stock | 1,600 | $1.93 | $3,088.00 |
DisclosureSEC source: 0001562180-19-005746 · primarydocument.xml · nonDerivative · entry 1 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,149 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2019 Filed Nov 19, 2019 23:18 UTC |
Duffy David C.SVP R&D and CTO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,667 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001562180-19-005590 · primarydocument.xml · derivative · entry 3 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,608 Underlying: Common Stock · 1,667 shares Expires 2021-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option is fully vested. Read SEC document |
| November 18, 2019 Filed Nov 19, 2019 23:18 UTC |
Duffy David C.SVP R&D and CTO
|
SaleCommon Stock | 1,667 | $22.56 | $37,614.69 |
DisclosureSEC source: 0001562180-19-005590 · primarydocument.xml · nonDerivative · entry 2 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,760 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on May 16, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $22.53 to $22.58. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 9,063 restricted stock units. Read SEC document |
| November 18, 2019 Filed Nov 19, 2019 23:18 UTC |
Duffy David C.SVP R&D and CTO
|
Exercise / conversionCommon Stock | 1,667 | $1.93 | $3,217.31 |
DisclosureSEC source: 0001562180-19-005590 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,427 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 13, 2019 Filed Nov 14, 2019 21:31 UTC |
Madaus Martin DDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,600 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001562180-19-005513 · primarydocument.xml · derivative · entry 8 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,107 Underlying: Common Stock · 1,600 shares Expires 2021-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: All options are vested and exercisable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.